ABP Developmental-Behavioral Pediatrics study materials
ABP Developmental-Behavioral Pediatrics study resources

ABP Developmental-Behavioral Pediatrics cheat sheet

ABP Developmental-Behavioral Pediatrics · Keep the key ideas within reach.

Quick reference

Typical and Atypical Development

  • Gross motor sequence: head control by 3-4 months, rolling 4-6 months, sitting unsupported 6-8 months, crawling 8-10 months, standing with support 9-10 months, independent walking 12-15 months.

  • Language sequence: cooing around 2 months, babbling around 6 months, canonical babbling 7-10 months, first words around 12 months, 50-word vocabulary by 18 months, two-word phrases by 18-24 months.

  • Refer for language evaluation if there is no babbling by 12 months, no single words by 16 months, no two-word phrases by 24 months, or any loss of language skills.

  • Growth rule: term birth weight doubles by about 5 months and triples by 12 months; length increases about 50% by 12 months; head circumference increases about 12 cm in the first year.

  • Red flags: persistent hand preference before 18 months, asymmetric movement, toe walking after 5 years, developmental regression, no social smile by 3 months, and failure to respond to sound.

  • Social-emotional sequence: social smile 6-8 weeks, stranger anxiety 6-9 months, separation anxiety 9-18 months, parallel play 2-3 years, cooperative play around 4 years.

  • Piaget milestones: object permanence 8-12 months, symbolic play 18-24 months, conservation around 7 years; these guide cognitive expectations but are not diagnostic thresholds.

  • Global developmental delay means significant delay in two or more domains in a child under 5 years; it warrants hearing evaluation, etiologic workup, and early intervention referral.

  • A fall across two or more major growth centiles, or a head circumference crossing centiles rapidly, is a growth red flag requiring evaluation.

Quick reference

Behavioral and Mental Health Conditions of Childhood

  • ADHD: for children under 17 years, at least 6 inattentive or hyperactive-impulsive symptoms; for age 17 and older, at least 5 symptoms; several symptoms before age 12; present in 2 or more settings; clear impairment.

  • Major depressive episode: at least 2 weeks of depressed or irritable mood or anhedonia plus 4 additional symptoms; irritability is common in children; assess suicide risk.

  • Oppositional defiant disorder: angry-irritable mood, argumentative-defiant behavior, or vindictiveness lasting at least 6 months and causing impairment; distinguish from developmentally normal oppositionality.

  • Conduct disorder: a repetitive pattern violating basic rights of others or major age-appropriate norms, including aggression, property destruction, deceit or theft, and serious rule violations.

  • Separation anxiety disorder: developmentally inappropriate, persistent fear of separation from attachment figures lasting at least 4 weeks in children and causing significant impairment.

  • PTSD: exposure to trauma plus intrusion, avoidance, negative cognition or mood, and arousal symptoms lasting more than 1 month and causing impairment.

  • OCD: obsessions or compulsions that are time-consuming, cause distress, or impair functioning; insight varies with age; comorbid tics and anxiety are common.

  • Tic disorders: provisional tic disorder if tics last less than 1 year; persistent tic disorder if motor or vocal tics last more than 1 year; Tourette disorder requires both motor and vocal tics for more than 1 year.

  • Enuresis: repeated voiding into bed or clothes at least twice weekly for 3 months or clinically significant distress in a child at least 5 years old; encopresis requires age at least 4 years and often involves constipation.

Quick reference

Neurodevelopmental and Genetic Disorders

  • Autism spectrum disorder: persistent deficits in social communication and social interaction plus restricted, repetitive patterns of behavior, interests, or activities; symptoms begin early and cause impairment.

  • Intellectual disability: deficits in intellectual functioning, such as reasoning or problem-solving, and deficits in adaptive functioning with onset during the developmental period.

  • Cerebral palsy: nonprogressive motor impairment from early brain injury or malformation; classify by tone, distribution, and Gross Motor Function Classification System level; screen for seizures, vision, hearing, and feeding problems.

  • Down syndrome: usually trisomy 21; screen for congenital heart disease, hearing loss, hypothyroidism, obstructive sleep apnea, and atlantoaxial instability; monitor growth on syndrome-specific charts.

  • Fragile X syndrome: FMR1 CGG repeat expansion above 200 causes intellectual disability, autism features, macroorchidism, long face, prominent ears, and anxiety; premutation carriers have distinct risks.

  • Rett syndrome: usually MECP2 variant in girls; early regression, loss of hand use, hand stereotypies, impaired communication, gait abnormalities, and seizures.

  • Tuberous sclerosis complex: TSC1 or TSC2 variants cause hamartomas, ash-leaf spots, seizures, developmental delay, and autism; surveillance includes brain, kidney, skin, and lung evaluation.

  • Duchenne muscular dystrophy: X-linked dystrophinopathy in boys; progressive proximal weakness, Gowers sign, elevated creatine kinase, calf pseudohypertrophy, and cardiomyopathy; consider steroid therapy.

  • Fetal alcohol spectrum disorder: prenatal alcohol exposure with sentinel facial features, growth deficiency, and central nervous system abnormalities; diagnosis requires a multidisciplinary assessment.

Quick reference

Assessment, Screening, and Diagnostic Evaluation

  • Sensitivity = true positives / (true positives + false negatives); specificity = true negatives / (true negatives + false positives).

  • Positive predictive value = true positives / all positive results; it rises with higher prevalence, so screening performance differs between low-risk and high-risk populations.

  • Developmental screening is recommended at 9, 18, and 30 months; autism-specific screening is recommended at 18 and 24 months using a validated parent-report tool.

  • M-CHAT-R scoring: total 0-2 is low risk; 3-7 is medium risk and requires the follow-up interview; 8-20 is high risk and warrants immediate referral for evaluation.

  • A diagnostic evaluation for developmental delay includes hearing and vision testing, developmental history, physical and neurologic examination, and standardized cognitive and adaptive measures.

  • Intellectual disability requires both low intellectual functioning, typically about 2 standard deviations below the mean, and adaptive behavior deficits; neither alone is sufficient.

  • First-tier etiologic testing for global developmental delay may include chromosomal microarray, fragile X testing, thyroid studies, lead level, and metabolic testing; brain MRI is guided by findings.

  • Children under 3 with developmental delay or established risk qualify for IDEA Part C early intervention; children 3 and older may qualify for IDEA Part B special education services.

  • Screening tools are not diagnostic; a positive screen requires diagnostic assessment, and a negative screen does not override clear clinical concern.

Quick reference

Intervention, Management, Advocacy, and Systems of Care

  • IDEA Part C: early intervention from birth through age 2, using an Individualized Family Service Plan; IDEA Part B preschool special education begins at age 3 and uses an Individualized Education Program.

  • Section 504 provides accommodations for a disability that substantially limits a major life activity but does not require special education; it is distinct from an IEP.

  • ADHD: for children under 6, behavioral parent training and environmental supports are first-line; for children 6 and older, medication plus behavioral treatment is recommended.

  • Pediatric anxiety: cognitive behavioral therapy is first-line; selective serotonin reuptake inhibitors are considered when therapy is insufficient or unavailable, with monitoring for activation and suicidality.

  • Pediatric depression: psychotherapy such as cognitive behavioral therapy or interpersonal therapy is first-line; fluoxetine is approved for ages 8 and older; monitor suicide risk closely.

  • Autism intervention: intensive behavioral and developmental approaches, speech-language therapy, occupational therapy, and parent-mediated strategies target communication, adaptive skills, and behavior.

  • Cerebral palsy management: multidisciplinary therapy, spasticity management, nutrition and feeding support, seizure treatment, and orthopedic surveillance; the underlying brain injury is nonprogressive.

  • Care coordination: the medical home should link families to early intervention, school services, specialty care, respite, and insurance or Medicaid programs such as EPSDT.

  • Transition planning: begin discussion of health, education, and vocational transition in early adolescence, with formal school transition planning by about age 14-16 depending on state requirements.